BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11432691)

  • 1. Behavioral characterization of Co 134444 (3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha- pregnan-20-one), a novel sedative-hypnotic neuroactive steroid.
    Vanover KE; Hogenkamp DJ; Lan NC; Gee KW; Carter RB
    Psychopharmacology (Berl); 2001 May; 155(3):285-91. PubMed ID: 11432691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents.
    Wieland S; Belluzzi JD; Stein L; Lan NC
    Psychopharmacology (Berl); 1995 Mar; 118(1):65-71. PubMed ID: 7597124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593.
    Wieland S; Belluzzi J; Hawkinson JE; Hogenkamp D; Upasani R; Stein L; Wood PL; Gee KW; Lan NC
    Psychopharmacology (Berl); 1997 Nov; 134(1):46-54. PubMed ID: 9399366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences in behavioral sensitivity to a neuroactive steroid.
    Finn DA; Roberts AJ; Lotrich F; Gallaher EJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):820-8. PubMed ID: 9023296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects.
    Gunter BW; Jones SA; Paul IA; Platt DM; Rowlett JK
    Psychopharmacology (Berl); 2016 Sep; 233(17):3237-47. PubMed ID: 27356519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the discriminative stimulus effects of the neuroactive steroid pregnanolone in DBA/2J and C57BL/6J inbred mice.
    Shannon EE; Porcu P; Purdy RH; Grant KA
    J Pharmacol Exp Ther; 2005 Aug; 314(2):675-85. PubMed ID: 15857945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted 3beta-phenylethynyl derivatives of 3alpha-hydroxy-5alpha-pregnan-20-one: remarkably potent neuroactive steroid modulators of gamma-aminobutyric acidA receptors.
    Hawkinson JE; Acosta-Burruel M; Yang KC; Hogenkamp DJ; Chen JS; Lan NC; Drewe JA; Whittemore ER; Woodward RM; Carter RB; Upasani RB
    J Pharmacol Exp Ther; 1998 Oct; 287(1):198-207. PubMed ID: 9765338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors.
    Vanover KE; Rosenzweig-Lipson S; Hawkinson JE; Lan NC; Belluzzi JD; Stein L; Barrett JE; Wood PL; Carter RB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):337-45. PubMed ID: 10991999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential change in neuroactive steroid sensitivity during ethanol withdrawal.
    Finn DA; Gallaher EJ; Crabbe JC
    J Pharmacol Exp Ther; 2000 Jan; 292(1):394-405. PubMed ID: 10604976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of a 17β-heteroaryl-substituted neuroactive steroid.
    Hogenkamp DJ; Tran MB; Yoshimura RF; Johnstone TB; Kanner R; Gee KW
    Psychopharmacology (Berl); 2014 Sep; 231(17):3517-24. PubMed ID: 24682501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of 16,17-dehydro-epipregnanolones: 17,20-bond torsional energy analysis and D-ring conformation.
    Bolger MB; Wieland S; Hawkinson JE; Xia H; Upasani R; Lan NC
    Pharm Res; 1996 Oct; 13(10):1488-94. PubMed ID: 8899839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of behavioral effects of drugs in mice by neuroactive steroids.
    Ungard JT; Beekman M; Gasior M; Carter RB; Dijkstra D; Witkin JM
    Psychopharmacology (Berl); 2000 Mar; 148(4):336-43. PubMed ID: 10928304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
    Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response-rate suppression in operant paradigm as predictor of soporific potency in rats and identification of three novel sedative-hypnotic neuroactive steroids.
    Vanover KE; Edgar DM; Seidel WF; Hogenkamp DJ; Fick DB; Lan NC; Gee KW; Carter RB
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1317-23. PubMed ID: 10565857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vivo interactions in mice between flurazepam and two neuroactive steroids.
    Deutsch SI; Rosse RB; Steinberg K; Morn C; Koetzner L; Riggs R; Mastropaolo J
    Pharmacol Biochem Behav; 1996 Nov; 55(3):323-6. PubMed ID: 8951972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
    Reddy DS; Rogawski MA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys.
    Rowlett JK; Winger G; Carter RB; Wood PL; Woods JH; Woolverton WL
    Psychopharmacology (Berl); 1999 Jul; 145(2):205-12. PubMed ID: 10463322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat.
    Edgar DM; Seidel WF; Gee KW; Lan NC; Field G; Xia H; Hawkinson JE; Wieland S; Carter RB; Wood PL
    J Pharmacol Exp Ther; 1997 Jul; 282(1):420-9. PubMed ID: 9223583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
    Kokate TG; Banks MK; Magee T; Yamaguchi S; Rogawski MA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):679-84. PubMed ID: 9918575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.